Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Junhyeong Yim | - |
dc.contributor.author | Junyoung Park | - |
dc.contributor.author | Gabin Kim | - |
dc.contributor.author | Hyung Ho Lee | - |
dc.contributor.author | Jin Soo Chung | - |
dc.contributor.author | Ala Jo | - |
dc.contributor.author | Minseob Koh | - |
dc.contributor.author | Jongmin Park | - |
dc.date.accessioned | 2024-12-12T07:02:00Z | - |
dc.date.available | 2024-12-12T07:02:00Z | - |
dc.date.created | 2024-10-28 | - |
dc.date.issued | 2024-11 | - |
dc.identifier.issn | 1860-7179 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/15567 | - |
dc.description.abstract | Proteolysis-targeting chimeras (PROTACs) have emerged as a promising technology for inducing targeted protein degradation by leveraging the intrinsic ubiquitin-proteasome system (UPS). While the potential druggability of PROTACs toward undruggable proteins has accelerated their rapid development and the wide-range of applications across diverse disease contexts, off-tissue effects and side-effects of PROTACs have recently received attentions to improve their efficacy. To address these issues, spatial or temporal target protein degradation by PROTACs has been spotlighted. In this review, we explore chemical strategies for modulating protein degradation in a cell type-specific (spatio−) and time-specific (temporal−) manner, thereby offering insights for expanding PROTAC applications to overcome the current limitations of target protein degradation strategy. © 2024 The Author(s). ChemMedChem published by Wiley-VCH GmbH. | - |
dc.language | 영어 | - |
dc.publisher | Wiley - V C H Verlag GmbbH & Co. | - |
dc.title | Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.wosid | 001336152300001 | - |
dc.identifier.scopusid | 2-s2.0-85206638552 | - |
dc.identifier.rimsid | 84325 | - |
dc.contributor.affiliatedAuthor | Ala Jo | - |
dc.identifier.doi | 10.1002/cmdc.202400326 | - |
dc.identifier.bibliographicCitation | ChemMedChem, v.19, no.22 | - |
dc.relation.isPartOf | ChemMedChem | - |
dc.citation.title | ChemMedChem | - |
dc.citation.volume | 19 | - |
dc.citation.number | 22 | - |
dc.description.journalClass | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | BIOORTHOGONAL CLICK CHEMISTRY | - |
dc.subject.keywordPlus | MEDIATED PHOTOTHERMAL THERAPY | - |
dc.subject.keywordPlus | ANTIBODY-DRUG CONJUGATE | - |
dc.subject.keywordPlus | OF-THE-ART | - |
dc.subject.keywordPlus | HYDROGEN-PEROXIDE | - |
dc.subject.keywordPlus | SONODYNAMIC THERAPY | - |
dc.subject.keywordPlus | INTRACELLULAR DELIVERY | - |
dc.subject.keywordPlus | PROTECTING GROUPS | - |
dc.subject.keywordPlus | FOLATE RECEPTOR | - |
dc.subject.keywordPlus | DNA-DAMAGE | - |
dc.subject.keywordAuthor | Targeted Protein Degradation (TPD) | - |
dc.subject.keywordAuthor | Temporal PROTAC | - |
dc.subject.keywordAuthor | PROTAC | - |
dc.subject.keywordAuthor | Spatial PROTAC | - |
dc.subject.keywordAuthor | Spatiotemporal PROTAC | - |